Invion (ASX:IVX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Invion (ASX:IVX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - IVX
Application for quotation of securities - IVX
Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor
Change of Directors' Interest Notices x 3
Notification regarding unquoted securities - IVX
Notification regarding unquoted securities - IVX
Notification regarding unquoted securities - IVX
Notification regarding unquoted securities - IVX
Application for quotation of securities - IVX
Results of Extraordinary General Meeting
Photosoft Platform Expands to Eye Diseases Via Partnership
Invion partners with SANGMYUNG to advance Photosoft technology for wet AMD treatment
Correction to Appendix 3Y - Alistair Bennallack
Notification of cessation of securities - IVX
Appendix 4C and Quarterly Activities Report - March 2026
Notice of General Meeting/Proxy Form
Bionnova 2026 Investor Presentation
Skin Cancer Trial Moves to BCC With More Encouraging Signals
Invion expands skin cancer trial to Basal Cell Carcinoma after positive safety and efficacy signals
Appendix 3Y Clarification
Change of Director's Interest Notice - Thian Chew